← Back to Clinical Trials
Recruiting NCT06551350

NCT06551350 Retrospective Assessment of Referral of a Major Trauma Patient

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06551350
Status Recruiting
Phase
Sponsor Hôpital NOVO
Condition Trauma Injury
Study Type OBSERVATIONAL
Enrollment 461 participants
Start Date 2024-10-18
Primary Completion 2025-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Data Collection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 461 participants in total. It began in 2024-10-18 with a primary completion date of 2025-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to find out whether major trauma patients from the Val d'Oise are referred to the appropriate trauma centre for their care and to assess the quality of triage within the Val d'Oise department.

Eligibility Criteria

Inclusion Criteria : * Between the 1st January 2023 and the 31th December 2023 * Regulated by SAMU 95 with suspected major trauma * Sending an MCIU * At least 1 Vittel criterion\* Exclusion Criteria : * Death on site * Care by an MICU team outside the 95 * Minor patients and legal protection * Transport refusals * Vittel criterion : • Physiological variables : Glasgow score \< 13 Systolic blood pressure \< 90 mmHg O2 saturation \< 90% • Elements of kinetics : Ejection from a vehicle Other passenger killed in the same vehicle Fall \> 6 metres Victim thrown or crushed Overall assessment (deformation of the vehicle, estimated speed, absence of helmet, absence of seatbelt) Blast • Anatomical lesions : Penetrating trauma to the head, neck, thorax, abdomen, pelvis, arm or thigh Flail chest Severe burn, smoke inhalation Pelvic fracture Suspected spinal cord injury Amputation of wrist, ankle or above Acute limb ischaemia • Pre-hospital resuscitation : Assisted ventilation Filling \> 1000 ml with colloids Catecholamines Inflated shock-proof trousers • Medical context (to be assessed) : Age \> 65 Cardiac or coronary insufficiency Respiratory insufficiency Pregnancy (2nd and 3rd trimesters) Blood crase disorders

Contact & Investigator

Central Contact

Maryline DELATTRE

✉ maryline.delattre@ght-novo.fr

📞 +3333130754131

Principal Investigator

Fabrice LOUVET

PRINCIPAL INVESTIGATOR

Hôpital NOVO

Frequently Asked Questions

Who can join the NCT06551350 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Trauma Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06551350 currently recruiting?

Yes, NCT06551350 is actively recruiting participants. Contact the research team at maryline.delattre@ght-novo.fr for enrollment information.

Where is the NCT06551350 trial being conducted?

This trial is being conducted at Pontoise, France.

Who is sponsoring the NCT06551350 clinical trial?

NCT06551350 is sponsored by Hôpital NOVO. The principal investigator is Fabrice LOUVET at Hôpital NOVO. The trial plans to enroll 461 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology